Kathy Yuen

Role: - Ä at Elucid
Location: Portland, OR, US
LinkedIn followers: 500 followers

OtherView LinkedIn profile

About Kathy Yuen

I graduated from University at Buffalo with a Masters of Architecture and a Masters of…

Experience

- Ä
Elucid
Present

Education

Bauhaus-Universität Weimar
Master of Architecture (M.Arch.), Media Architecture
2012 — 2012
University at Buffalo
M.Arch I & MFA in Media Production, Media Architecture
2010 — 2013
University at Buffalo
Bachelor of Science - BS, Architecture
2005 — 2010

Skills

Architectural Drawings
Python
Adobe Photoshop
Java
Human Computer Interaction
Interaction Design
Architectural Design
Rhino
User Experience Design
Html5
Graphic Design
Sketchup
Arduino
Javascript
Creative Coding
Photoshop
Parametric Design
Illustrator
Adobe Creative Suite
Adobe Illustrator
Microsoft Office
Rendering
Design Research
Vray
3d Modeling
Model Making
Programming
Digital Fabrication
Autocad
Sketching
Indesign
Architecture
Revit

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@elucid.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Elucid

Medical Equipment Manufacturing · 141 employees · Founded 2013 · Boston, Massachusetts, United States

Elucid is a Boston-based AI medical technology company that develops AI to see invisible features of risk. The company is dedicated to developing a clinical platform to help physicians deliver CCTA-guided personalized care by providing a more precise view of atherosclerosis, the root cause of cardiovascular disease. The company’s FDA-cleared Plaque-IQ™ image analysis software is designed to help physicians prioritize and personalize treatment based on actual disease, rather than population-based risk of disease. Plaque-IQ equips physicians with critical information regarding the type and amount of plaque in arteries that can lead to heart attack and stroke. Elucid is also pursuing an indication for FFR-CT, derived from its plaque algorithm, resulting in concordance between plaque and FFR-CT. FFR-CT helps physicians identify coronary blockages and the extent of a patient’s ischemia non-invasively. For more information, visit elucid.com.

elucid.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.